线虫抗凝血蛋白c2的融合表达及其抗凝活性分析

目的:在大肠杆菌中表达硫氧还蛋白-线虫抗凝血蛋白c2(Trx-NAPc2)融合蛋白,并检测其抗凝活性。方法:将扩增的NAPc2基因经BamHⅠ和HindⅢ双酶切后连接到表达载体pET-32a中,转化至大肠杆菌BL21(DE3),分别经IPTG和乳糖诱导表达;表达产物经镍琼脂糖凝胶FF纯化后,用体外凝血酶原时间(PT)和活化部分凝血活酶时间(aPTT)试验检测抗凝血活性。结果:构建了pET-32a/NAPc2表达质粒,并在大肠杆菌BL21(DE3)中高效表达,表达产物主要以可溶形式存在,纯化的Trx-NAPc2融合蛋白能明显延长PT及aPTT。结论:在大肠杆菌中高效表达了具有生物活性的Trx-NAPc2融合蛋白,为进一步研究NAPc2的功能及应用奠定了基础。     

黔产剑叶凤尾蕨的化学成分研究

为研究剑叶凤尾蕨(Pteris ensiformis)的化学成分,该研究选用硅胶、凝胶、MCI、C₁₈等柱色谱进行分离纯化,结合¹H-NMR、¹³C-NMR、MS、IR等波谱数据鉴定化合物结构,并通过MTS和APTT、PT以及TT等方法对所分离得到的部分单体化合物进行抗肿瘤和抗凝血活性筛选。结果表明：(1)从剑叶凤尾蕨中分离得到15个化合物,分别为2-羟基-乙酰基吡咯(1)、N-(3-羧丙基)-2-乙酰基吡咯(2)、3-羟基-2-甲基吡啶(3)、N-甲基羟胺(4)、pterosin S 13-O-glucoside(5)、obtupterosin C(6)、ent-11α-hydroxy-15-oxokauran-19-oic acid(7)、ent-11α-hydroxy-15-oxokaur-16-en-19-oic acid(8)、β-谷甾醇(9)、ent-11α-hydroxy-15-oxokaur-16-en-19-oic acid-O-glucopyranoside(10)、5, 5′-二丁氧基-2, 2′-...     

Tick saliva: recent advances and implications for vector competence

Abstract . Secretions of the tick salivary glands are essential to the successful completion of the prolonged feeding of these ectoparasites as well as the conduit by which most tick-borne pathogens are transmitted to the host. In ixodid ticks the salivary glands are the organs of osmoregulation, and excess water from the bloodmeal is returned via saliva into the host. Host blood must continue to flow into the feeding lesion as well as remain fluid in the tick mouthparts and gut. The host's haemostatic mechanisms are thwarted by various anti-platelet aggregatory, anticoagulatory and anti-vasoconstrictory factors in tick saliva. Saliva components suppress the immune and inflammatory response of the host permitting the ticks to remain on the host for an extended period of time and, adventitiously, enhancing the transmission and establishment of tick-borne pathogens. Over the years much work has been done on the numerous enzyme and pharmacological activities found in the tick saliva. The present article reviews the most recent work on salivary gland secretionith special emphasis on how they favour pathogen transmission.     

中药抗血栓作用的研究

对复方丹参、五虎散、活络效灵丹、四藤汤、云南白药、复方绞股兰、水八角和伏毛肥肉草,采用人体抗凝血浆进行了常规凝血指标及纤维蛋白溶解试验的测定。结果表明,复方丹参、四藤汤、复方绞股兰、水八角和伏毛肥肉草有显著的抗凝作用,五虎散、活络效灵丹和云南白药也有较明显的抗凝作用。     

A Study of Two Procedures of HIV-1 Isolation from Whole Blood Cultures

Culture techniques for isolation of HIV-1 from small amounts of whole blood (WB) treated with anticoagulant have been reported and gave results identical to those of culture of separated peripheral blood mononuclear cells. Some authors obtained much higher isolation rates when EDTA was used instead of heparin. We compared two previously described techniques for cultivation of HIV-1 from WB of adult HIV+ patients staged according to the CDC classification. In addition, we assessed the influence of the type of anticoagulant used for the collection of blood in viral replication in cell cultures from whole blood. Small volumes of WB treated with either heparin or EDTA were cocultivated with phytohemagglutinin (PHA)-stimulated peripheral blood mononuclear cells (PHA-PBMC) from healthy donors. We used two procedures for WB culture: procedure I, based on the culture of 250 μl of WB with 1 × 10⁶ PHA-PBMC from donors; and procedure II based on the culture of 500 μl of WB with 4× 10⁶ PHA-PBMC from donors. The cocultures were placed in 24-well plates and incubated for as long as 28 days in medium containing interleukin 2 (IL-2). Twice weekly half of the medium was replaced with fresh medium. In procedure II, one million fresh PHA-PBMC from donors was added on the 7th day of culture. The culture supernatant was assayed for the presence of HIV-1 p24 antigen in an enzyme immunoassay. The kinetics of HIV-1 replication in cultures of WB from 7 AIDS patients were similar using procedures I and II. In 8 HIV + patients the isolation rate was higher with heparin- than with EDTA-treated samples. The isolation rate was higher in AIDS patients (n = 8) than in others with both methods. In stage IV patients without AIDS (n = 8) we failed to isolate HIV-1 in 1 patient with procedure I, whereas we succeeded with procedure II. In stage II, HIV-I was isolated in 1 of 4 patients with both methods. HIV was isolated in cultures of WB from patients receiving zidovudine or related nucleoside analogues and in cultures of WB from untreated patients. HIV-1 could not be isolated from WB of patients with more than 400 CD4+ T lymphocytes in their peripheral blood (n=4); however, it was isolated from 14 of 16 patients with less than 400 CD4+ T lymphocytes. Our results suggest that procedure II is more sensitive than procedure I and that heparin is better than EDTA for collecting WB. We showed that the rate of HIV-1 isolation from WB increased in advanced-stage patients. Further studies are needed to define the clinical applications of WB culture.     

Isolation and characterization of an anticoagulant from the salivary glands of the tick, Ornithodoros savignyi (Acari: Argasidae)

An inhibitor of activated coagulation factor X (fXa) was isolated from salivary gland extracts prepared from Ornithodoros savignyi using a two-step procedure, involving reversed-phase high-performance liquid chromatography (RP-HPLC) and diethylaminoethyl (DEAE) ion-exchange chromatography. From its behaviour during DEAE chromatography it could be deduced that it possesses an acidic pI (4.6). Capillary zone electrophoresis (CZE) of the purified inhibitor showed it to be homogeneous. The molecular mass was determined as 12 kDa using capillary gel electrophoresis (CGE) and as 7183.4 using laser desorption mass spectrometry (LDMS). The N-terminal amino acid sequence (residues 1–12) was determined and found to share a 66% identity with tick anticoagulant peptide (TAP). The O. savignyi peptide is a slow, tight-binding inhibitor of fXa (K _i=0.83±0.10 nM). The interaction of the fXa-inhibitor was found to be competitive and dependent on ionic strength. Preliminary investigations show that the inhibitor may be specific for fXa.Deceased.     

Production of biologically active hirudin in plant seeds using oleosin partitioning

A plant oleosin was used as a carrier for the production of the leech anticoagulant protein, hirudin (variant 2). The oleosin-hirudin fusion protein was expressed and accumulated in seeds. Seed-specific expression of the oleosin-hirudin fusion mRNA was directed via an Arabidopsis oleosin promoter. The fusion protein was correctly targeted to the oil body membrane and separated from the majority of other seed proteins by flotation centrifugation. Recombinant hirudin was localized to the surface of oil bodies as determined by immunofluorescent techniques. The oleosin-hirudin fusion protein accumulated to ca. 1% of the total seed protein. Hirudin was released from the surface of the oil bodies using endoprotease treatment. Recombinant hirudin was partially purified through anion exchange chromatography and reverse-phase chromatography. Hirudin activity, measured in anti-thrombin units (ATU), was observed in seed oil body extracts, but only after the proteolytic release of hirudin from its oleosin carrier. About 0.55 ATU per milligram of oil body protein was detected in cleaved oil body preparations. This activity demonstrated linear dose dependence. The oleosin fusion protein system provides a unique route for the large-scale production of recombinant proteins in plants, as well as an efficient process for purification of the desired polypeptide.